T. Rowe Price Small-Mid Cap ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.55
資產淨值: 40.71
成立日期: 14/06/2023
 
分析
市值分佈:
93.15%
大市值
6.18%
中市值
0.27%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:07) 總持有投資項目: 281  
0%
 
100%
     10大 (10.82%)
代號 名稱 佔比% 持有日期
APGEApogee Therapeutics0.0929/04/2026
NAVNNavan Inc0.0929/04/2026
KODKodiak Sciences0.0829/04/2026
BEAMBeam Therapeutics0.0829/04/2026
HMHHMH Holding Inc.0.0829/04/2026
COGTCogent Biosciences0.0829/04/2026
SYRESpyre Therapeutics0.0729/04/2026
GLXYGalaxy Digital Inc0.0729/04/2026
RAREUltragenyx Pharmaceutical0.0729/04/2026
CAICaris Life Sciences Inc0.0729/04/2026
DNTHDianthus Therapeutics0.0729/04/2026
STOKStoke Therapeutics0.0729/04/2026
BLLNBilliontoone Inc0.0629/04/2026
WVEWave Life Sciences Ltd0.0529/04/2026
VRDNViridian Therapeutics0.0529/04/2026
TYRATyra Biosciences0.0529/04/2026
IEIvanhoe Electric0.0529/04/2026
BCAXBicara Therapeutics Inc.0.0529/04/2026
XNCRXencor0.0329/04/2026
MPLTMapLight Therapeutics Inc.0.0329/04/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13   14    15  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.